Effects of platelet concentrate storage time reduction in patients after blood stem cell transplantation

The impact of platelet transfusion characteristics on posttransfusion platelet increments and clinical bleeding in patients with hypoproliferative thrombocytopenia

(2012) D. J. Triulzi et al.   BLOOD

Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study

(2012) Hannes Wandt et al.   LANCET

Safety and clinical efficacy of platelet components prepared with pathogen inactivation in routine use for thrombocytopenic patients

(2011) Peter Schlenke et al.   ANNALS OF HEMATOLOGY

Konventionelle vs. pathogeninaktivierte Thrombozytenkonzentrate bei perioperativer Koagulopathie

(2011) C.F. Weber et al.   CHIRURG

The hemostatic efficacy of platelet components prepared with pathogen inactivation

(2011) Laurence Corash   TRANSFUSION

Adjudicating bleeding events in a platelet dose study: impact on outcome results and challenges

(2011) Nancy M. Heddle et al.   TRANSFUSION

Transfusion-Transmitted Bacterial Infections – Haemovigilance Data of German Blood Establishments (1997–2010)

(2011) Markus B. Funk et al.   TRANSFUSION MEDICINE AND HEMOTHERAPY

10 Years Experience with Bacterial Screening of Platelet Concentrates in the Netherlands

(2011) Dirk de Korte   TRANSFUSION MEDICINE AND HEMOTHERAPY

Extension of platelet shelf life from 4 to 5 days by implementation of a new screening strategy in Germany

(2011) W. Sireis et al.   VOX SANGUINIS

Dose of Prophylactic Platelet Transfusions and Prevention of Hemorrhage

(2010) Sherrill J. Slichter et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effects of storage duration and volume on the quality of leukoreduced apheresis-derived platelets: implications for pediatric transfusion medicine

(2010) Anne M. Winkler et al.   TRANSFUSION

A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology

(2010) J-P. Cazenave et al.   TRANSFUSION

Monitoring bacterial contamination of blood components in Germany: effect of contamination reduction measures

(2010) G. Walther-Wenke et al.   VOX SANGUINIS

Festlegung der Haltbarkeitsfrist von Thrombozytenkonzentraten mit dem Ziel der Reduktion lebensbedrohlicher septischer Transfusionsreaktionen durch bakterielle Kontamination

(2009)   Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz

Therapeutic efficacy of platelet transfusion in patients with acute leukemia: an evaluation of methods

(2009) Torunn O. Apelseth et al.   TRANSFUSION

Pathogen reduction technology (Mirasol®) treated single-donor platelets resuspended in a mixture of autologous plasma and PAS

(2009) K. Janetzko et al.   VOX SANGUINIS

A randomized controlled trial comparing standard- and low-dose strategies for transfusion of platelets (SToP) to patients with thrombocytopenia

(2008) N. M. Heddle et al.   BLOOD

Patient and product factors affecting platelet transfusion results

(2008) Dominik Heim et al.   TRANSFUSION

Comparing the efficacy and safety of apheresis and whole bloodderived platelet transfusions: a systematic review

(2008) Nancy M. Heddle et al.   TRANSFUSION

Buffy-coat platelet variables and metabolism during storage in additive solutions or plasma

(2008) Jerry G. Zhang et al.   TRANSFUSION